Aware that CXCR4 could be a valuable prognostic factor in cancer [15,16,17,18,19] and a therapeutic target [44,45], it has been hypothesized that CXCR4 expression could be a useful tool to help decision-making in patients with high-risk soft tissue tumors [19,46]. The gene discussed is CXCR4; the disease is cancer.